Skip to main content
BC Innovations
Feature Story

Cover Story: Tools & Techniques: Innate harmony

Why NK cells are the next big thing in immuno-oncology

By Lauren Martz, Senior Writer

On the heels of cancer immunotherapy's clinical success, NK cells - a long-known but underappreciated component of the innate immune system - are emerging as the hottest new tool to fight cancer, with the potential to be safer and more broadly effective than their adaptive immune system counterparts.

The excitement centers on the potential of NK cells to solve some of the challenges of chimeric antigen receptor (CAR) T cells, allowing companies to bring together the immune system's innate and adaptive arms in a more comprehensive approach to creating tumor immunotherapies.

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial